1.To what extent were course objectives met to cover (5 being the best and 1 being not at all):

1

2

3

4

5

Up-to-date criteria for the diagnosis of selected common and less common entities and important, recently reported tumor variants.

1

2

3

4

5

Use of appropriate ancillary immunohistochemical studies and molecular genetic assays in the work-up.

1

2

3

4

5

Guidance on dealing with challenging lesions and avoidance of pitfalls contributing to misdiagnosis.

1

2

3

4

5

2.To what extent were (5 being the completely and 1 being not at all):

1

2

3

4

5

Course contents up-to-date.

1

2

3

4

5

Slides and handouts useful to learning.

1

2

3

4

5

Your questions answered.

1

2

3

4

5

Your interactions via email with faculty sufficient.

1

2

3

4

5

Subjects covered useful to your practice.

1

2

3

4

5

Online Experience Satisfactory

1

2

3

4

5

3.2/1/2021 Please rate the following presentations (5 being the best and 1 being not at all):

1

2

3

4

5

7:30am Correlation, Concordance and other Considerations for Core Biopsy (Laura Collins, M.D.)

1

2

3

4

5

8:30am Diagnostic Dilemmas in Ductal Proliferations (Laura Collins, M.D.)

1

2

3

4

5

9:30am Pancreatic Ductal Adenocarcinoma and Its Variants in the Neoadjuvant Era (Aatur Singhi)

1

2

3

4

5

11:00am Interpretation of Reactive and Dysplastic Changes in Barrett's Esophagus (Lisa Yerian, M.D.)

1

2

3

4

5

12:00pm Updates and Approach to the WHO Classification of Adult Renal Neoplasia, including Medullary-Based Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.)

1

2

3

4

5

4.2/2/2021 Please rate the following presentations (5 being the best and 1 being not at all):

1

2

3

4

5

N/A

7:30am The Diagnosis of Cystic and Intraductal Neoplasms of the Pancreas (Aatur Singhi, M.D., Ph.D.)

1

2

3

4

5

N/A

8:30am Making Sense of Nomenclature, WHO Grading and Staging of Pancreatic Neuroendocrine Neoplasms (Aatur Singhi, M.D., Ph.D.)

1

2

3

4

5

N/A

9:30am Overview of Nonneoplastic Gastric Pathology (Lisa Yerian, M.D.)

1

2

3

4

5

N/A

11:00am Updates in Onococytic Adult Renal Neoplasia (Michelle Hirsch, M.D., Ph.D.)

1

2

3

4

5

N/A

12:00pm A Lesson on Lobular Lesions (Laura Collins, M.D.)

1

2

3

4

5

N/A

5.2/3/2021 Please rate the following presentations (5 being the best and 1 being not at all):

1

2

3

4

5

N/A

7:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 1 (Lisa Yerian, M.D.)

1

2

3

4

5

N/A

8:30am Applying a Pattern-Based Approach to Liver Biopsy Interpretation Part 2 (Lisa Yerian, M.D.)

1

2

3

4

5

N/A

9:30am A Contemporary Approach to Prostatic Adenocarcinoma, Including Poor Prognostic Indicators (Michelle Hirsch, M.D., Ph.D.)

1

2

3

4

5

N/A

11:00am Pesky Papillary Lesions (Laura Collins, M.D.)

1

2

3

4

5

N/A

12:00pm The Challenges of Gallbladder and Biliary Pathology (Aatur Singhi, M.D., Ph.D.)

1

2

3

4

5

N/A

6.2/4/2021 Please rate the following presentations (5 being the best and 1 being not at all):

1

2

3

4

5

N/A

7:30am Having Fun with Testicular Tumors (Michelle Hirsch, M.D., Ph.D.)

1

2

3

4

5

N/A

8:30am Practical Points and Biomarkers in GU Pathology (Michelle Hirsch, M.D., Ph.D.)

1

2

3

4

5

N/A

9:30am Unique and Unusual Breast Lesions (Laura Collins, M.D.)

1

2

3

4

5

N/A

11:00am Pancreatobiliary Frozen Section Nightmares (Aatur Singhi, M.D., Ph.D.)

1

2

3

4

5

N/A

12:00pm Liver Transplant Pathology (Lisa Yerian, M.D.)

1

2

3

4

5

N/A

7.Did you email the speakers during you had during their lectures?  If so, were your questions answered?  If you did not email them, why?

8.Specialty (please check one):

Surgical Pathologist

Clinical Pathologist

Dermatopathologist

Pathology Resident

Pathology Fellow

Cytopathologist

Pathologist Assist.

9.Years in practice:

10.How did you learn about this program? (Please check one)

Email Blast

Internet Search

Word of mouth

Pathology Outlines.com

SSI Website

Previous attendee

Other (please specify)

11.What Factors Influenced You to Attend this Online Course?  Please rate the
order of importance how the following factors influenced your decision to attend this course from 6 (Most) to 1 (Least):                   

1

2

3

4

5

6

Location (Online)

1

2

3

4

5

6

CME Credits

1

2

3

4

5

6

Course Topics

1

2

3

4

5

6

Faculty

1

2

3

4

5

6

Company Reputation

1

2

3

4

5

6

Online Option

1

2

3

4

5

6

12.Which Season of the Year is Best for You? Please rate from 1 (Best) to 5 (Least):

1

2

3

4

5

6

Winter

1

2

3

4

5

6

Spring

1

2

3

4

5

6

Summer

1

2

3

4

5

6

Fall

1

2

3

4

5

6

Anytime if Online is available

1

2

3

4

5

6

13.Please rate each attribute 1 to 5 (5 = Excellent, 1 = Poor):

1

2

3

4

5

Educational Handouts

1

2

3

4

5

Level of material presented

1

2

3

4

5

Interaction with speakers via Email

1

2

3

4

5

Length of course

1

2

3

4

5

Convenience

1

2

3

4

5

Faculty

1

2

3

4

5

Audio visuals

1

2

3

4

5

Course Organization

1

2

3

4

5

14.Did this course help you identify specific gaps in your knowledge/practice?  If so which areas?

15.Do you feel this course enhanced your professional abilities? If so how?

16.In which areas in pathology do you feel are in greatest need of CME?

17.Would You attend More SSI Online Courses?

Yes

No

18.What did you like/dislike about the Online Experience?